First, by using quantitative real-time PCR and a paired t-test statistical analysis, we demonstrated that PRMT5 expression was higher in pancreatic adenocarcinoma (PDAC) tumor samples than in adjacent samples (Fig. 1a). This evidence concerns the gene PRMT5 and neoplasm.